Lescarden Inc. (LCAR) - Financial and Strategic SWOT Analysis Review

Document Sample
Lescarden Inc. (LCAR) - Financial and Strategic SWOT Analysis Review Powered By Docstoc
					        Lescarden Inc. (LCAR) - Financial and Strategic SWOT Analysis Review
        Reference Code: GDPH61133FSA                                                                                          Publication Date: SEP 2012

          Suite 212, 420 Lexington Ave                       Phone              +1 212 6871050                  Revenue          0.4 (million USD)
          New York, NY                                       Fax                +1 212 6871051                  Net Profit       -0.19 (million USD)
          10170                                              Website            www.catrix.com                  Employees        1
                                                                                LCAR     [Over          The                      Pharmaceuticals           &
          United States                                      Exchange                                           Industry
                                                                                Counter]                                         Healthcare

       Company Overview
       Lescarden Inc. (Lescarden) is a biotechnology company with focus on the development and commercialization of therapy
       products in the therapeutic areas of clinical skin care, wound healing, osteoarthritis, cancer and autoimmune applications. The
       company offers its lead products under Catrix brand including Catrix Wound Dressing, Catrix Skin Care and Nutritional
       Supplements. It offers nutritional supplements, including Bio-Cartilage, and Poly-NAG, a glucosamine polymer for the treatment
       of osteoarthritis.
       Share Data                                                                    SWOT Analysis
         Lescarden Inc.                                                               Lescarden Inc., SWOT Analysis
        Share Price (USD) as on 17-Sep-                                  0.02         Strengths                              Weaknesses
        2012
                                                                                                                             Dependence on Third Party
        EPS (USD)                                                         NA          Effective Distribution Network
                                                                                                                             Manufacturers
        Market Cap (million USD)                                            1         Strong Product Performance
                                                                                                                             Limited Number of Customers
        Enterprise Value (million USD)                                      1
        Shares Outstanding (million)                                       40
       Source: Annual Report, Company Website, Primary and Secondary
                                                                                      Opportunities                          Threats
       Research, GlobalData
                                                                                      Poly-NAG For Veterinary                Competitive Pressures
                                                                                      Market
                                                                                                                             Stringent Regulatory
                                                                                      Increase in Life Expectancy            Requirements


                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData

       Financial Performance




       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Lescarden Inc. (LCAR) - Financial and Strategic SWOT Analysis                                                                  Reference Code: GDPH61133FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 4
       Lescarden Inc. - Key Facts ................................................................................................................................................................. 4
       Lescarden Inc. - Major Products and Services ................................................................................................................................... 5
       Lescarden Inc. - History...................................................................................................................................................................... 6
       Lescarden Inc. - Company Statement ................................................................................................................................................ 7
       Lescarden Inc. - Locations And Subsidiaries...................................................................................................................................... 9
          Head Office ..................................................................................................................................................................................... 9
       Section 2 – Company Analysis ......................................................................................................................................................... 10
       Lescarden Inc. - Business Description ............................................................................................................................................. 10
       Lescarden Inc. - SWOT Analysis...................................................................................................................................................... 11
          SWOT Analysis - Overview........................................................................................................................................................... 11
          Lescarden Inc. - Strengths ............................................................................................................................................................ 11
             Strength - Effective Distribution Network ................................................................................................................................... 11
             Strength - Strong Product Performance .................................................................................................................................... 11
             Strength - Strong Intellectual Property ...................................................................................................................................... 11
          Lescarden Inc. - Weaknesses....................................................................................................................................................... 11
             Weakness - Dependence on Third Party Manufacturers ........................................................................................................... 11
             Weakness - Limited Number of Customers ............................................................................................................................... 12
          Lescarden Inc. - Opportunities ...................................................................................................................................................... 12
             Opportunity - Poly-NAG For Veterinary Market ......................................................................................................................... 12
             Opportunity - Increase in Life Expectancy ................................................................................................................................. 12
             Opportunity - Market Potential: Chronic Wounds ...................................................................................................................... 12
          Lescarden Inc. - Threats ............................................................................................................................................................... 12
             Threat - Competitive Pressures ................................................................................................................................................. 12
             Threat - Stringent Regulatory Requirements ............................................................................................................................. 13
             Threat - High Dependency on Supplier ..................................................................................................................................... 13
       Lescarden Inc. - Key Competitors .................................................................................................................................................... 14
       Section 3 – Company Financial Ratios ............................................................................................................................................. 15
       Financial Ratios - Capital Market Ratios.....................................
				
DOCUMENT INFO
Description: Lescarden Inc. (Lescarden) is a biotechnology company with focus on the development and commercialization of therapy products in the therapeutic areas of clinical skin care, wound healing, osteoarthritis, cancer and autoimmune applications. The company offers its lead products under Catrix brand including Catrix Wound Dressing, Catrix Skin Care and Nutritional Supplements. It offers nutritional supplements, including Bio-Cartilage, and Poly-NAG, a glucosamine polymer for the treatment of osteoarthritis. It markets its lead commercial product, Catrix wound dressing as a powder derived from bovine cartilage which is effective in the management of chronic lesions and burns and for non-healing wounds such as decubitus ulcers, venous stasis ulcers, and diabetic ulcers. It also provides the products in plastic surgery, dermatology and medical spa markets. The company operates in the markets of Canada, Europe, Iceland, Republic of Korea and the US. Lescarden is headquartered in New York, the US. The company focuses on to seek marketing and licensing opportunities for fully developed patented products and are ready for commercialization.
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.